An electrocatalytic glucose sensor for in vivo application has been de
veloped to determine the glucose level in blood and further to control
the insulin dosage in a closed loop system for diabetes therapy. The
principle of the electrocatalytic glucose sensor is based on the direc
t electrochemical oxidation of glucose at a membrane-covered platinum
electrode. For a possible clinical application the sensor was built as
a catheter. A set of implantations in the vena cava of sheep demonstr
ated the potential feasibility of the sensor. The sensor values were s
imultaneously checked by the enzymatic analysis of glucose in blood sa
mples drawn separately from a femoral vein. It was possible to determi
ne the glucose concentration in sheep for more than 130 days with tole
rable deviations from glucose reference measurements. The mean error w
as 2.5 mmol/l. One of the catheters was explanted after 211 days and t
he histological examination revealed a good biocompatibility of all ma
terials used. In additional experiments, the differences of the glucos
e concentration in vena cava as well as in the anterior and posterior
femoral veins of a sheep were examined during glucose tolerance tests.
These experiments verified our method of in vivo calibration of the l
ong-term implantable glucose sensor.